During the past decade, Department of Hematology Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Department of Hematology Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology" #1 collaborator was "CSPC Ouyi Pharmaceutical Co., Ltd." with 1 trials as a collaborator and "The First Affiliated Hospital of Nanchang University" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Department of Hematology Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology" are "Diffuse Large B-cell Lymphoma" (1 trials), "Lymphoma" (1 trials) and "Relapse/Recurrence" (1 trials). Many other conditions were trialed in "Department of Hematology Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology" in a lesser frequency.

Most popular intervention types in "Department of Hematology Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology" are "Drug" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "CD30 CAR-T" (1 trials), "Camrelizumab" (1 trials), "Lenalidomide" (1 trials), "Mitoxantrone Hydrochloride Liposome" (1 trials) and "Rituximab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Department of Hematology Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Department of Hematology Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology". 1 are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Department of Hematology Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Department of Hematology Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".